{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:26Z","timestamp":1791520946941,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI1101537"],"award-info":[{"award-number":["PI1101537"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"- Sociedad Espa\u00f1ola de Reumatolog\u00eda Pedi\u00e1trica (SERPE)"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad of Spain","doi-asserted-by":"crossref","award":["CP11\/00314"],"award-info":[{"award-number":["CP11\/00314"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12969-017-0190-0","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T06:04:05Z","timestamp":1502085845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Immunogenicity and safety of influenza vaccination in patients with juvenile idiopathic arthritis on biological therapy using the microneutralization assay"],"prefix":"10.1186","volume":"15","author":[{"given":"M. S.","family":"Camacho-Lovillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bulnes-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Goycochea-Valdivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fern\u00e1ndez-Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"N\u00fa\u00f1ez-Cuadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Neth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"P\u00e9rez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"key":"190_CR1","doi-asserted-by":"crossref","unstructured":"Dell\u2019 Era L, Esposito S, Corona F, Principi N. Vaccination of children and adolescents with rheumatic diseases. Rheumatology (Oxford) [Internet]. 2011;50(8):1358\u20131365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21482543 .","DOI":"10.1093\/rheumatology\/ker102"},{"key":"190_CR2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. Clin Infect Dis. 2014;58:e44\u2013100.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"190_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.autrev.2011.08.010","volume":"11","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Borrow R, van der Klis F, Kon\u00e9-Paut I, Fasth A, et al. Vaccination in paediatric patients with auto-immune rheumatic diseases: A systemic literature review for the European League against Rheumatism evidence-based recommendations. Autoimmun Rev. 2011;11(2):112\u201322.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"190_CR4","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/ard.2011.150193","volume":"70","author":"MW Heijstek","year":"2011","unstructured":"Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, F K-PI v d K. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. 2011;70(10):1704\u201312.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"190_CR5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027214","volume":"6","author":"JL Miraglia","year":"2011","unstructured":"Miraglia JL, Abdala E, Hoff PM, Luiz AM, Oliveira DS, Saad CGS, et al. Immunogenicity and reactogenicity of 2009 influenza a (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients. PLoS One. 2011;6(11):e27214.","journal-title":"PLoS One"},{"issue":"10","key":"190_CR6","first-page":"1769","volume":"20","author":"PN Malleson","year":"1993","unstructured":"Malleson PN, Tekano JL, Scheifele DWWJ. Influenza immunization in children with chronic arthritis: a prospective study. J Rheumatol. 1993;Oct;20(10):1769\u20137.","journal-title":"J Rheumatol"},{"issue":"2","key":"190_CR7","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg JHX, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor MEWP, Rheumatology. IL of A for. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u20132.","journal-title":"J Rheumatol"},{"key":"190_CR8","doi-asserted-by":"crossref","unstructured":"Carvalho LM, De Paula FE, Silvestre RVD, Roberti LR, Arruda E, Mello WA, et al. Prospective surveillance study of acute respiratory infections, influenza-like illness and seasonal influenza vaccine in a cohort of juvenile idiopathic arthritis patients. Pediatr Rheumatol. 2013;11:10.","DOI":"10.1186\/1546-0096-11-10"},{"issue":"6","key":"190_CR9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/s10165-012-0595-z","volume":"22","author":"T Shinoki","year":"2012","unstructured":"Shinoki T, Hara R, Kaneko U, Miyamae T, Imagawa T, Mori M, et al. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab. Mod Rheumatol. 2012;22(6):871\u20136.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"190_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/INF.0b013e3181f7ce44","volume":"30","author":"C Ogimi","year":"2011","unstructured":"Ogimi C, Tanaka R, Saitoh A, Oh-Ishi T. Immunogenicity of Influenza Vaccine in Children With Pediatric Rheumatic Diseases Receiving Immunosuppressive Agents. Pediatr Infect Dis J. 2011;30(3):208\u201311.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"190_CR11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and Validation of a Composite Disease Activity Score for Juvenile Idiopathic Arthritis. Arthritis Care Res. 2009;61(5):658\u201366.","journal-title":"Arthritis Care Res"},{"key":"190_CR12","unstructured":"The Global Vaccine Safety Initiative (GVSI [Internet]. Available from: http:\/\/www.who.int\/vaccine_safety\/initiative\/en . Accessed July 2016."},{"issue":"5","key":"190_CR13","first-page":"1058","volume":"29","author":"HI Brunner","year":"2002","unstructured":"Brunner HI, Lovell DJ, Finck BKGE. Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol. 2002;29(5):1058\u201364.","journal-title":"J Rheumatol"},{"issue":"11","key":"190_CR14","doi-asserted-by":"crossref","first-page":"1040.e11","DOI":"10.1016\/j.cmi.2015.07.014","volume":"21","author":"P Perez-Romero","year":"2015","unstructured":"Perez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavald\u00e1 J, Aydillo TA, Moreno A, et al. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe. Clin Microbiol Infect. 2015;21(11):1040.e11\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"190_CR15","unstructured":"The European Agency for the Evaluation of Medicinal Products (EMEA). Comitte for Proprietary Medicinal Products (CPMP). Note for guidence on harmonisation of requirements for influenza vaccines. WwwEudraOrg\/EmeaHtml [Internet]. 1997;19. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003945.pdf . Accessed July 2016."},{"issue":"4","key":"190_CR16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/vaccines2040707","volume":"2","author":"C Trombetta","year":"2014","unstructured":"Trombetta C, Perini D, Mather S, Temperton N, Montomoli E. Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future. Vaccine. 2014;2(4):707\u201334. Available from: http:\/\/www.mdpi.com\/2076-393X\/2\/4\/707\/","journal-title":"Vaccine"},{"key":"190_CR17","doi-asserted-by":"crossref","unstructured":"Consolaro A, Giancane G, Schiappapietra B, Dav\u00ec S, Calandra S, Lanni S, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):23. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27089922%5Cn, http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC4836071","DOI":"10.1186\/s12969-016-0085-5"},{"key":"190_CR18","first-page":"436","volume":"30","author":"N Toplak","year":"2012","unstructured":"Toplak N, \u0160ubelj V, Kveder T, \u010cu\u010dnik S, Prosenc K, Trampu\u0161-Bakija A, et al. Paediatric rheumatology Safety and efficacy of influenza vaccination in a prospective longitudinal study of 31 children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2012;30:436\u201344.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"190_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0131531","volume":"10","author":"CP Verschoor","year":"2015","unstructured":"Verschoor CP, Singh P, Russell ML, Bowdish DME, Brewer A, Cyr L, et al. Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children. PLoS One. 2015;10(6):7\u201313.","journal-title":"PLoS One"},{"issue":"12","key":"190_CR20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","volume":"30","author":"S Black","year":"2012","unstructured":"Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, et al. Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children. Pediatr Infect Dis J. 2012;30(12):1081\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"190_CR21","doi-asserted-by":"crossref","unstructured":"Cagigi A, Cotugno N, Rinaldi S, Santilli V, Rossi P, Palma P. Downfall of the current antibody correlates of influenza vaccine response in yearly vaccinated subjects: Toward qualitative rather than quantitative assays. Pediatr Allergy Immunol 2016;27(1):22\u20137.","DOI":"10.1111\/pai.12483"},{"key":"190_CR22","doi-asserted-by":"crossref","unstructured":"Shirota Y, Yarboro C, Fischer R, Pham T, Lipsky P, Illei GG. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.\u00a0Ann Rheum Dis. 2013;72(1):118\u201328.","DOI":"10.1136\/annrheumdis-2012-201310"},{"key":"190_CR23","doi-asserted-by":"crossref","unstructured":"Chioato A, Noseda E, Felix SD, Stevens M, Del Giudice G, Fitoussi S, et al. Influenza and meningococcal vaccinations are effective in healthy subjects treated with the interleukin-1-blocking antibody canakinumab: Results of an open-label, parallel group, randomized, single-center study. Clin Vaccine Immunol. 2010;17(12):1952\u20137.","DOI":"10.1128\/CVI.00175-10"},{"issue":"6","key":"190_CR24","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1186\/ar3542","volume":"13","author":"JJ Kobie","year":"2011","unstructured":"Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, et al. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther. 2011;13(6):R209. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22177419 .","journal-title":"Arthritis Res Ther"},{"key":"190_CR25","doi-asserted-by":"crossref","unstructured":"Dell\u2019Era L, Corona F, Daleno C, Scala A, Principi N, Esposito S. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine. 2012;20;30(5):936\u201340.","DOI":"10.1016\/j.vaccine.2011.11.083"},{"key":"190_CR26","doi-asserted-by":"crossref","unstructured":"Aikawa NE, Campos LMA, Goldenstein-Schainberg C, Saad CGS, Ribeiro AC, Bueno C, et al. Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis. Scand J Rheumatol [Internet]. 2013;42(1):34\u201340. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22992045 .","DOI":"10.3109\/03009742.2012.709272"},{"issue":"12","key":"190_CR27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/hv.7.12.17981","volume":"7","author":"A Woerner","year":"2011","unstructured":"Woerner A, Sauvain M-J, Aebi C, Otth M, Bolt IB. Immune response to influenza vaccination in children treated with methotrexate or\/and tumor necrosis factor-alpha inhibitors. Hum Vaccin. 2011;7(12):1293\u20138.","journal-title":"Hum Vaccin"},{"issue":"1","key":"190_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10067-013-2435-8","volume":"33","author":"C Sengler","year":"2014","unstructured":"Sengler C, Niewerth M, Kallinich T, Nimtz-Talaska A, Haller M, Huppertz HI, et al. Survey about tolerance of the AS03-adjuvanted H1N1 influenza vaccine in children with rheumatic diseases. Clin Rheumatol. 2014;33(1):137\u20139.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"190_CR29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.vaccine.2014.12.030","volume":"33","author":"NE Aikawa","year":"2015","unstructured":"Aikawa NE, Fran\u00e7a ILA, Ribeiro AC, Sallum AME, Bonfa E, Silva CA. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy. Vaccine. 2015;33(5):604\u20139.","journal-title":"Vaccine"},{"issue":"7","key":"190_CR30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/acr.21948","volume":"65","author":"LMA Campos","year":"2013","unstructured":"Campos LMA, Silva CA, Aikawa NE, Jesus AA, Moraes JCB, Miraglia J, et al. High disease activity: An independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care Res. 2013;65(7):1121\u20137.","journal-title":"Arthritis Care Res"},{"issue":"25\u201326","key":"190_CR31","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1016\/S0264-410X(03)00309-8","volume":"21","author":"P Trzonkowski","year":"2003","unstructured":"Trzonkowski P, My\u015bliwska J, Szmit E, Wi\u0229ckiewicz J, \u0141ukaszuk K, Brydak LB, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - An impact of immunosenescence. Vaccine. 2003;21(25\u201326):3826\u201336.","journal-title":"Vaccine"},{"key":"190_CR32","doi-asserted-by":"crossref","unstructured":"Cordero E, Aydillo TA, Perez-Ordo\u00f1ez A, Torre-Cisneros J, Lara R, Segura C, et al. Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients. Transplantation [Internet]. 2012;93(8):847\u2013854. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22377789","DOI":"10.1097\/TP.0b013e318247a6ef"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-017-0190-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T22:52:55Z","timestamp":1569970375000},"score":1,"resource":{"primary":{"URL":"http:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-017-0190-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["190"],"URL":"https:\/\/doi.org\/10.1186\/s12969-017-0190-0","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]},"article-number":"62"}}